Altimmune, Inc.ALTNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P14
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-455.00%
2024-95.31%
2023726.47%
2022-101.54%
2021117.41%
2020-536.52%
2019171.37%
201855.74%
2017-822.27%
2016-135.70%